Allergan Plc's Business Segments

Allergan plc is a global pharmaceutical company that was founded in 1950 in California, USA. It specializes in developing, manufacturing, and marketing branded pharmaceuticals, biologics, medical devices, and over-the-counter products for the treatment of neurological, ophthalmologic, medical aesthetics, and gastroenterological conditions.

Allergan is based in Dublin, Ireland, and operates in around 100 countries worldwide. It employs more than 18,000 people across its research and development, manufacturing, and commercial operations. In 2020, the company reported annual revenue of $16.6 billion.

The company's portfolio of products includes Botox, which is used for cosmetic and medical purposes, as well as treatments for eye diseases, migraines, irritable bowel syndrome, and other conditions. Some of Allergan's leading brands include Juvederm, Coolsculpting, Latisse, Restasis, and Ozurdex.

Allergan has a strong focus on research and development, investing heavily in clinical trials and innovation. The company has research facilities in the US, Europe, and Asia, and collaborates with other organizations and academic institutions to advance scientific discovery in its areas of focus.

In 2019, Allergan was acquired by AbbVie, a research-based pharmaceutical company based in North Chicago, Illinois, in a deal worth $63 billion. The acquisition positioned AbbVie as a leading pharmaceutical company with a diverse portfolio of medicines and products, including Allergan's portfolio of medical aesthetics and eye care products.

Overall, Allergan is a leading global pharmaceutical company with a strong reputation for innovation and a diverse portfolio of products that help improve the lives of patients.

Allergan plc, a prominent global pharmaceutical company, operates through a diverse portfolio of segments that aim to enhance healthcare outcomes across multiple domains. Here’s an extensive overview of its key segments, products, and services:

Medical Aesthetics Segment
Allergans medical aesthetics segment is recognized for its innovative products that focus on improving the aesthetic appearance of individuals. This includes:

1. Injectables:
- BOTOX®: A botulinum toxin type A injectable that temporarily relaxes facial muscles, effectively reducing the appearance of frown lines, crow’s feet, and forehead wrinkles. It is also utilized for other medical conditions such as excessive sweating and certain migraines.
- JUVÉDERM®: A collection of hyaluronic acid-based dermal fillers. These products offer solutions for facial volume loss, wrinkles, and enhancing lips, providing instant results in contouring and facial aesthetics.
- KYBELLA®: The first and only FDA-approved injectable treatment specifically designed to reduce submental fat, commonly referred to as a double chin.

2. Plastic Surgery Products: Allergan also supports surgical enhancements, including breast implants and tissue expanders, catering to various cosmetic and reconstructive needs.

Eye Care Segment
The eye care segment emphasizes products formulated for various ocular conditions, improving patients visual health and quality of life:

1. Prescription Eye Drops:
- RESTASIS®: A pivotal treatment for chronic dry eye, helping to increase tear production in patients who do not have sufficient tear flow.
- Lumigan® (Bimatoprost): An ophthalmic solution that lowers intraocular pressure in patients with glaucoma.

2. Sustained-Release Treatments:
- OZURDEX®: An implant that delivers dexamethasone, designed for the treatment of retinal diseases such as macular edema and non-infectious uveitis.

3. Eyebrow Products:
- LUMIGENES®: A solution intended to enhance eyelash fullness and appear darker.

Central Nervous System Segment
Allergans central nervous system segment predominantly targets neurological disorders, focusing on therapies that improve the quality of life for patients experiencing chronic conditions:

1. Migraine Treatments:
- BOTOX® for Chronic Migraines: Administered as a preventive treatment to reduce the frequency of migraine episodes in adult patients.

2. Alzheimer’s Disease:
- NAMZARIC®: A combination product of donepezil and memantine, aimed at treating patients with moderate to severe Alzheimer’s disease.

3. Psychiatric Disorders:
- VRAYLAR®: Approved for the treatment of schizophrenia and as a treatment for manic or mixed episodes in bipolar I disorder.

Women’s Health Segment
Focusing on a wide array of conditions specific to women, this segment’s products are designed to address significant issues in reproductive health:

1. Hormonal Contraceptives:
- Lo Loestrin Fe®: A low-dose oral contraceptive pill that effectively prevents pregnancy while managing menstrual symptoms.
- MONOPHASIC 21®: An oral contraceptive that helps regulate menstrual cycles and reduce menstrual-related symptoms.

2. Menopausal Relief:
- Vaginal Creams: Such as VANOS®, provide relief from vulvar itching or skin conditions related to menopause.

3. Endometriosis Treatments: Initiatives in this space focus on managing pain associated with endometriosis, enhancing womens health outcomes.

Gastroenterology Segment
Allergans gastroenterology segment addresses gastrointestinal disorders that significantly impact daily living:

1. Constipation Treatments:
- LINZESS®: Designed for chronic idiopathic constipation and irritable bowel syndrome (IBS) with constipation, promoting regular bowel movements and alleviating discomfort.
- AMITIZA®: Provides relief for adult patients suffering from chronic constipation and IBS, enhancing intestinal motility.

2. Approaches to Digestive Disorders: The segment engages in research to develop and improve therapies for other gastrointestinal conditions, continuing to expand its impact in this field.

Summary
In summary, Allergan plc operates a comprehensive portfolio across various healthcare segments, which includes innovative treatments in medical aesthetics, eye care, central nervous system disorders, womens health, and gastroenterology. Each segment is dedicated to enhancing the quality of life for patients and addressing prevalent health challenges through advanced pharmaceutical solutions. The company’s commitment to research and development is crucial in introducing new therapies and improving existing products, thereby playing a vital role in the healthcare industry.